Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yinghui Wang"'
Autor:
James E. Hoffman, Brea Lipe, Jason Melear, Michaela Liedtke, Mark A. Schroeder, Ruben Niesvizky, Christopher Strouse, Christopher A. Yasenchak, Damian J. Green, Jeremy Sauer, Yinghui Wang, Phoenix Ho, Al-Ola Abdallah
Publikováno v:
Blood. 140:10160-10162
Autor:
Christopher A. Yasenchak, Phoenix A. Ho, Damian J. Green, James E. Hoffman, Jason M. Melear, Al-Ola Abdallah, Mark A. Schroeder, Brea Lipe, Yinghui Wang, Michael H. Tomasson, Michaela Liedtke, Ruben Niesvizky, Hong Li
Publikováno v:
Blood. 138:2740-2740
Background Patients (pts) with relapsed/triple-class refractory (R/R; refractory to a proteasome inhibitor, immunomodulatory drug or anti-CD38 antibody) multiple myeloma (MM) have limited treatment options. A need remains for novel combination therap
Autor:
Beata Holkova, Maria Corinna Palanca-Wessels, Andres Forero-Torres, Christopher A. Yasenchak, Robert T. Chen, Rodolfo Bordoni, Jeff P. Sharman, Jerome H. Goldschmidt, Yinghui Wang, Gregg Olsen, Jonathan W. Friedberg, Ralph V. Boccia
Publikováno v:
Blood. 126:2798-2804
Outcomes in older patients with Hodgkin lymphoma (HL) tend to be poor following conventional chemotherapy regimens. Treatment-related toxicity is significant and comorbidities often limit therapeutic options. This phase 2, open-label study evaluated
Autor:
Paolo Caimi, Howland E. Crosswell, Ahmed Sawas, R. Gregory Bociek, Andres Forero-Torres, Stephen M. Ansell, Jeffrey Matous, Miguel Islas-Ohlmayer, Edward Agura, Ann S. LaCasce, Julie M. Vose, Yinghui Wang, Owen A. O'Connor, Eric C. Cheung, Neil C Josephson, Ranjana H. Advani, Caroline Behler
Autologous stem cell transplantation (ASCT) is standard of care for patients with Hodgkin lymphoma (HL) who have relapsed/refractory disease after frontline chemotherapy. Achievement of complete remission (CR) with pre-ASCT salvage chemotherapy predi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ac3ad9df9285b9760f5845c10a95bbc
https://europepmc.org/articles/PMC6073588/
https://europepmc.org/articles/PMC6073588/
Autor:
Yinghui Wang, Erin Zagadailov, Youn H. Kim, Pascal Wolter, Steven M. Horwitz, Madeleine Duvic, Pier Luigi Zinzani, William L. Trepicchio, Meredith Little, Maria Corinna Palanca-Wessels, Reinhard Dummer, Yi Liu, Sean Whittaker, Julia Scarisbrick, H. Miles Prince, Pietro Quaglino
Publikováno v:
Blood. 128:182-182
Background Cutaneous T cell lymphoma (CTCL) is a chronic disease that negatively impacts quality of life (QoL) and, in advanced stages, has poor prognosis. Current systemic therapies rarely provide reliable and durable responses, and to date, no syst
Autor:
LaCasce, Ann S.1 ann_lacasce@dfci.harvard.edu, Bociek, R. Gregory2, Sawas, Ahmed3, Caimi, Paolo4, Agura, Edward5, Matous, Jeffrey6, Ansell, Stephen M.7, Crosswell, Howland E.8, Islas-Ohlmayer, Miguel9, Behler, Caroline10, Cheung, Eric11, Forero-Torres, Andres12, Vose, Julie2, O'Connor, Owen A.3, Josephson, Neil13, Yinghui Wang13, Advani, Ranjana14
Publikováno v:
Blood. 7/5/2018, Vol. 132 Issue 1, p40-48. 9p.
Autor:
Friedberg, Jonathan W.1 jonathan_friedberg@urmc.rochester.edu, Forero-Torres, Andres2, Bordoni, Rodolfo E.3, Cline, Vivian J. M.4, Donnelly, Dipti Patel5, Flynn, Patrick J.6, Olsen, Gregg7, Chen, Robert8, Fong, Abraham9, Yinghui Wang9, Yasenchak, Christopher A.10
Publikováno v:
Blood. 12/28/2017, Vol. 130 Issue 26, p2829-2837. 9p.
Autor:
Forero-Torres, Andres1 aforero@uab.edu, Holkova, Beata2, Goldschmidt, Jerome3, Chen, Robert4, Olsen, Gregg5, Boccia, Ralph V.6, Bordoni, Rodolfo E.7, Friedberg, Jonathan W.8, Sharman, Jeff P.9, Palanca-Wessels, Maria Corinna10, Yinghui Wang10, Yasenchak, Christopher A.9
Publikováno v:
Blood. 12/24/2015, Vol. 126 Issue 26, p2798-2804. 7p.